Company profile
Microbiome Therapeutics Innovation Group
Leading the research and development of FDA-approved microbiome therapeutics and microbiome-based products
- Industry
- Biotechnology Research
- Employees
- 7
- Headquarters
- Washington, D.C.
- LinkedIn followers
- 12,958
- Office locations
- 1
Microbiome Therapeutics Innovation Group company summary
Microbiome Therapeutics Innovation Group is a company in the Biotechnology Research industry, headquartered in Washington, D.C.. On LinkedIn the company has around 7 employees and 12,958 followers.
What technology does Microbiome Therapeutics Innovation Group use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Microbiome Therapeutics Innovation Group
The Microbiome Therapeutics Innovation Group (MTIG) is a coalition of companies leading the research and development of FDA-approved microbiome therapeutics and microbiome-based products to address unmet medical needs, improve clinical outcomes, and reduce health care costs. The human microbiome is one of the new frontiers of medical innovation that has the potential to benefit patients suffering from numerous diseases afflicting millions of patients and consuming billions of dollars of healthcare resources. MTIG is committed to working with stakeholders who share in our mission and seek tangible policy and regulatory solutions in the emerging microbiome arena. Through a collective voice, the MTIG membership works together to enhance the regulatory, investment, and commercial environment to accelerate microbiome therapeutic product development and enable the field to reach its potential to benefit patients. Today, MTIG is comprised of eleven microbiome therapeutics companies: Alveolus Bio, Bio-Me, BiomeSense, Genetic Analysis, Microba Life Sciences, Rebiotix Inc., Seres Therapeutics, Inc., Servatus Biopharmaceuticals, Siolta Therapeutics, Takeda Pharmaceutical Company Limited and Vedanta Biosciences.
Where is Microbiome Therapeutics Innovation Group located?
Microbiome Therapeutics Innovation Group lists 1 location.
Compare companies similar to Microbiome Therapeutics Innovation Group
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Microbiome Therapeutics Innovation Group microbiometig.org | Biotechnology Research | 7 | - | Washington, D.C. |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Microbiome Therapeutics Innovation Group
What does Microbiome Therapeutics Innovation Group do?
The Microbiome Therapeutics Innovation Group (MTIG) is a coalition of companies leading the research and development of FDA-approved microbiome therapeutics and microbiome-based products to address unmet medical needs, improve clinical outcomes, and reduce health care costs. The human microbiome is one of the new frontiers of medical innovation that has the potential to benefit patients suffering from numerous diseases afflicting millions of patients and consuming billions of dollars of healthcare resources. MTIG is committed to working with stakeholders who share in our mission and seek tangible policy and regulatory solutions in the emerging microbiome arena. Through a collective voice, the MTIG membership works together to enhance the regulatory, investment, and commercial environment to accelerate microbiome therapeutic product development and enable the field to reach its potential to benefit patients. Today, MTIG is comprised of eleven microbiome therapeutics companies: Alveolus Bio, Bio-Me, BiomeSense, Genetic Analysis, Microba Life Sciences, Rebiotix Inc., Seres Therapeutics, Inc., Servatus Biopharmaceuticals, Siolta Therapeutics, Takeda Pharmaceutical Company Limited and Vedanta Biosciences.
How many employees does Microbiome Therapeutics Innovation Group have?
Microbiome Therapeutics Innovation Group has around 7 employees on LinkedIn.
Where is Microbiome Therapeutics Innovation Group headquartered?
Microbiome Therapeutics Innovation Group is headquartered in Washington, D.C..
Build a lead list from companies like Microbiome Therapeutics Innovation Group
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.